We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register to chat with like-minded investors on our interactive forums.
| Share Name | Share Symbol | Market | Type |
|---|---|---|---|
| Masimo Corporation | NASDAQ:MASI | NASDAQ | Common Stock |
| Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
|---|---|---|---|---|---|---|---|---|---|---|
| 2.55 | 2.05% | 126.65 | 126.53 | 126.66 | 127.62 | 122.365 | 124.10 | 820,504 | 22:15:03 |
From May 2023 to May 2024
By Stephen Nakrosis
Masimo on Friday said the Masimo W1 medical watch received 510(k) clearance from the U.S. Food and Drug Administration for over-the-counter and prescription use
The Masimo W1 is "the first FDA-cleared watch to provide continuous real-time oxygen saturation and pulse rate for OTC and Rx use," the company said.
Data from the integrated Masimo MW-1 module is displayed in real-time on the Masimo W1 watch touchscreen, the company said.
Section 510(k) of the Food, Drug and Cosmetic Act requires manufacturers to give the FDA 90 days advance notice before they can market a medical device.
Write to Stephen Nakrosis at stephen.nakrosis@wsj.com
(END) Dow Jones Newswires
November 17, 2023 16:58 ET (21:58 GMT)
Copyright (c) 2023 Dow Jones & Company, Inc.
1 Year Masimo Chart |
1 Month Masimo Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
